EUVIMEDEUVIMED entdecken
Crossref

CYTOTOXIC ACTIVITY OF EPETRABOROLE AGAINST CANCER CELL LINES

Anara Babayeva, Bekir Çöl

Kocaeli Üniversitesi Sağlık Bilimleri Dergisi · 31.05.2026 · 12 (2) · 109-114

DOI: 10.30934/kusbed.1864288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kocaeli Üniversitesi Sağlık Bilimleri Dergisi, online erschienen am 31.05.2026. Verfasst von Anara Babayeva und 1 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Antibiotic repurposing represents a promising strategy in oncology, utilizing well-characterized pharmacophores to exploit conserved vulnerabilities in cancer cells. This study aimed to evaluate the cytotoxic potential of epetraborole (EP), a benzoxaborole-class leucyl-tRNA synthetase inhibitor, against various cancer cell types.

Methods

The cytotoxic effects of EP were assessed in five cancer cell lines: malignant mesothelioma (CARM-L12 TG3), osteosarcoma (MG63), and colorectal carcinomas (HT-29, SW-48, and 2A3). MTT cell viability assays were conducted to determine dose- and time-dependent responses following 72-hour exposure. Antibacterial activity was verified by determining the minimum inhibitory concentration (MIC) against Escherichia coli.

Results

EP exhibited significant cytotoxic activity in a dose- and time-dependent manner. The compound showed highest potency against CARM-L12 TG3 (IC50= 0.408 ± 1.1 µg/mL) and MG63 (IC₅₀ = 0.875 ± 1.6 µg/mL) cell lines, while colorectal carcinoma cells were less sensitive (IC50 > 3 µg/mL). Antibacterial testing confirmed EP’s bioactivity, with an MIC value of 0.5 μg/mL against E. coli.

Conclusion

Epetraborole demonstrates strong cytotoxic potential, particularly against mesenchymal-derived cancers such as mesothelioma and osteosarcoma. These results suggest that EP is a promising candidate for repurposing in oncology, targeting malignancies dependent on protein synthesis machinery.

Zitieren

APA

Babayeva, A., & Çöl, B. (2026). CYTOTOXIC ACTIVITY OF EPETRABOROLE AGAINST CANCER CELL LINES. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi, 12(2), 109-114. https://doi.org/10.30934/kusbed.1864288

Vancouver

Babayeva A, Çöl B. CYTOTOXIC ACTIVITY OF EPETRABOROLE AGAINST CANCER CELL LINES. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi. 2026;12(2):109-114. doi:10.30934/kusbed.1864288

BibTeX
@article{Babayeva2026,
  author = {Babayeva, Anara and Çöl, Bekir},
  title = {CYTOTOXIC ACTIVITY OF EPETRABOROLE AGAINST CANCER CELL LINES},
  journal = {Kocaeli Üniversitesi Sağlık Bilimleri Dergisi},
  year = {2026},
  volume = {12},
  number = {2},
  pages = {109--114},
  doi = {10.30934/kusbed.1864288}
}
Kostenlos starten →